Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?
about
Data collection and analysis strategies for phMRIHeterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging.A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapyPhysicochemical characterization of nebulized superparamagnetic iron oxide nanoparticles (SPIONs).In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesA comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging.Quantitative β mapping for calibrated fMRI.Safety and technique of ferumoxytol administration for MRI.Intracellular performance of tailored nanoparticle tracers in magnetic particle imaging.Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.Ferumoxytol administration does not alter infarct volume or the inflammatory response to stroke in miceAssessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA).Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer.Lymph node imaging in initial staging of prostate cancer: An overview and update.
P2860
Q30773900-061AB64C-7C83-470A-BA46-4335BC600A5CQ30838654-759605E2-F33F-457E-A544-B4119C328C58Q34477467-B9056D39-2432-4CC8-9BE5-EBAE5ADEB03DQ35200143-D713EBE0-9AC4-4708-BCE5-0AF5654938B6Q36289257-A63D86AF-4D40-4EE7-84B7-B88C34FB63B0Q36301599-217F63F2-6F58-46FF-8DA1-2E3A4A00878FQ36522707-2E71366F-247C-4842-B09D-9CEC47F8C577Q36862859-8E5449E3-70A8-4C73-8907-63F8EC884C31Q37688657-76EB3BA8-0E7F-4091-9291-75A26FA959CFQ38539866-6717CA18-DCE5-48BD-AD22-CCC5D41C6148Q41755970-F71B0488-A25A-4F51-B8B4-1087021D63A5Q41847007-2D143B81-E622-40EE-B8D3-06412306024FQ47103693-D551053C-1ADD-4214-897C-B628871A017AQ47150560-7F900C79-7743-4BD1-9BDD-16F25A7BC0DCQ47157403-C8BC5AAB-3871-4078-95EE-D089F714A70B
P2860
Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ferumoxytol: a silver lining i ...... disease or another dark cloud?
@en
Ferumoxytol: a silver lining i ...... disease or another dark cloud?
@nl
type
label
Ferumoxytol: a silver lining i ...... disease or another dark cloud?
@en
Ferumoxytol: a silver lining i ...... disease or another dark cloud?
@nl
prefLabel
Ferumoxytol: a silver lining i ...... disease or another dark cloud?
@en
Ferumoxytol: a silver lining i ...... disease or another dark cloud?
@nl
P2860
P356
P1476
Ferumoxytol: a silver lining i ...... disease or another dark cloud?
@en
P2093
Adinoyi O Garba
Amy Barton Pai
P2860
P356
10.2147/JBM.S29204
P577
2012-08-29T00:00:00Z